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Background
Randomised controlled trials can provide robust evi-
dence to inform clinical care of mental health service
users. A core outcome set (COS) for use in research
into schizophrenia and bipolar has the potential to
reduce reporting bias and increase the ability of
reviewers to synthesise results of randomised controlled
trials. There is no core outcome set currently available
for use in this research area.
The aim of this study is to develop a COS for use in
research into schizophrenia and bipolar disorder in a
community setting.
Materials and methods
A group of participants representing the key stakeholder
groups, including service users, carers, health and social
care professionals and commissioners, will be recruited
from the United Kingdom.
Focus groups and one-to-one interviews, led by aca-
demic and service user researchers, will seek to identify
clinical, social, psychological and physical outcomes that
are important to key stakeholders. An iterative, constant
comparative and thematic analysis will identify key out-
comes and will be supplemented by outcomes identified
through a review of literature.
An online, three round, Delphi study with key stake-
holders will reduce the range of potential outcomes to a
smaller core set. On completion of the Delphi Study a
face-to-face consensus meeting will be held to ratify the
final outcomes.
A systematic or rapid literature review will assess the
properties of existing measures used in research with
bipolar and schizophrenia populations. Measures identi-
fied will be matched with the outcomes from the Delphi
study for consideration and confirmation at a later sta-
keholder meeting.
Conclusions
A COS represents the minimum measurement require-
ment for trials within a research area. It is anticipated
that this work will increase the use of stakeholder rele-
vant outcomes and improve our ability interpret and
compare the results of studies involving people with
schizophrenia and bipolar in a community setting.
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